Science Explorer Interactive view Map
Company · Ulm · Germany

Teva Pharmaceuticals (Germany)

Research works
28
▼ 49% vs 2013–17
Citations
339
12.2 per fractional work
Top-10% rate
6.9%
record average 16.5%
Open access
41%
world 28%

Not ranked overall: Teva Pharmaceuticals (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.74× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 5.39× its world share, 0 worksImmunology and Micro…Neuroscience: 4.82× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 8.62× its world share, 0 worksPharmacology, Toxico…Engineering: 0.05× its world share, 0 worksEngineeringMathematics: 2.22× its world share, 0 worksMathematicsMedicine: 3.96× its world share, 4 worksMedicinePsychology: 0.08× its world share, 0 worksPsychologyworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.6×. Every wedge is a field page.

Which keywords describe research at Teva Pharmaceuticals (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Circadian Rhythms, Neurological Disorders, Chemotherapy, Cancer, Antimicrobial Agents, Febrile Neutropenia, Memory and Sleep.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Circadian Rhythms4▲ 169×2 topics
  2. Neurological Disorders4▲ 20×10 topics
  3. Epidemiology3▲ 3.0×10 topics
  4. Chemotherapy3▲ 16×3 topics
  5. Cancer3▲ 7.8×3 topics
  6. Antimicrobial Agents3▲ 530×1 topic
  7. Febrile Neutropenia3▲ 530×1 topic
  8. Memory2▲ 34×1 topic
  9. Sleep2▲ 214×1 topic
  10. Headache Disorders2▲ 307×1 topic
  11. Migraine2▲ 168×1 topic
  12. Diagnostic Criteria2▲ 34×5 topics
  13. Oxidative Stress2▲ 3.9×7 topics
  14. Genetic Mutations2▲ 12×2 topics
  15. Hematopoietic Stem Cells2▲ 61×2 topics
  16. Meta-Analysis2▲ 11×3 topics
  17. Treatment2▲ 4.8×5 topics
  18. Congenital Disorders2▲ 263×1 topic
  19. Insomnia2▲ 115×1 topic
  20. Neutropenia2▲ 263×1 topic
  21. Sleep Duration2▲ 126×1 topic
  22. Quality of Life1▲ 3.1×2 topics
  23. Monoclonal Antibodies1▲ 28×2 topics

Which research topics does Teva Pharmaceuticals (Germany) publish most on?

By volume in 2022–2025: Migraine and Headache Studies, Fibromyalgia and Chronic Fatigue Syndrome Research, Vestibular and auditory disorders and Peripheral Neuropathies and Disorders.

  1. 1 Migraine and Headache Studies Psychiatry and Mental health 1 works
  2. 2 Fibromyalgia and Chronic Fatigue Syndrome Research Psychiatry and Mental health 0 works
  3. 3 Vestibular and auditory disorders Neurology 0 works
  4. 4 Peripheral Neuropathies and Disorders Neurology 0 works
  5. 5 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 0 works
  6. 6 Neurological Complications and Syndromes Psychiatry and Mental health 0 works
  7. 7 Biosimilars and Bioanalytical Methods Immunology 0 works
  8. 8 Bone health and treatments Oncology 0 works
  9. 9 Hemodynamic Monitoring and Therapy Surgery 0 works
  10. 10 Statistical Methods in Clinical Trials Statistics and Probability 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.7%not open59.3%

World: 28% of research is openly available.

with international co-authors47.9%domestic only52.1%

World: 19% is written across borders.

How has Teva Pharmaceuticals (Germany)'s research output changed?

Output in 2018–2022 was 49% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Ulm

All research institutions in Ulm

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.